Viewing Study NCT06480500

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-26 @ 12:18 PM
Ignite Modification Date: 2026-03-03 @ 8:09 AM
Study NCT ID: NCT06480500
Status: RECRUITING
Last Update Posted: 2025-12-05
First Post: 2022-03-16
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: i-CBT and IV Ketamine for Suicidality in Treatment-Resistant Depression: A Randomized, Midazolam-Controlled Clinical Trial
Sponsor: University Health Network, Toronto
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Major Depressive Disorder View
None Suicide View
None Treatment Resistant Depression View
Keywords:

Keywords

Keyword Brief Keyword Text View
None MDD View
None Ketamine View
None Internet-Based Cognitive Behavioural Therapy View
None Suicide View